Tumor recurrence in hepatocellular carcinoma (HCC) patients after radiofrequency ablation
(RFA) remains common; some studies have reported that insufficient ablative margin after …

Background Radio frequency ablation (RFA) of hepatocellular carcinoma has proved to be
useful in local control of tumor. A few data on survival after treatment are available in …

Results There were no significant differences in gender, etiology, and tumor stage between
the two groups. Five-year survival rate in the PEI group was 40% and 51% in the RFA group …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide.
HCC is generally considered to spread via the bloodstream and local recurrence often …

Methods We retrospectively studied 100 Korean patients with early HCC. Prognostic factors
for survival were analysed by univariate and multivariate analysis using the Kaplan-Meier …

AIM: To evaluate a series of patients with hepatocellular carcinoma (HCC) treated with
several different protocols and devices. METHODS: We treated 138 patients [chronic …

Results Fifty one patients were included. Median follow-up duration was 14.2 months.
Twenty patients experienced tumor recurrence. Multivariable analyses showed that low …

Background Radiofrequency ablation (RFA) is currently an effective method for ablation of
hepatocellular carcinoma (HCC). Early reports have indicated that RFA is safe and virtually …

Objective: This study was undertaken to assess the outcome of potentially curative
radiofrequency ablation (RFA) therapy for early-stage hepatocellular carcinoma (HCC) in …

Background: Radiofrequency ablation (RFA) is used to treat early-stage hepatocellular
carcinoma (HCC), but is sometimes avoided in patients with decompensated liver cirrhosis …